GALENA BIOPHARMA INC's ticker is and the CUSIP is 363256908. A total of 3 filers reported holding GALENA BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,375,000 | -28.1% | 3,925,400 | -4.3% | 0.02% | -34.8% |
| Q2 2016 | $1,913,000 | -61.5% | 4,103,700 | +12.3% | 0.02% | -67.1% |
| Q1 2016 | $4,969,000 | +342.9% | 3,653,900 | +378.7% | 0.07% | +438.5% |
| Q4 2015 | $1,122,000 | -2.9% | 763,300 | +4.4% | 0.01% | -18.8% |
| Q3 2015 | $1,155,000 | -35.9% | 731,200 | -31.1% | 0.02% | -36.0% |
| Q2 2015 | $1,803,000 | +81.6% | 1,060,600 | +48.4% | 0.02% | +56.2% |
| Q1 2015 | $993,000 | -2.2% | 714,700 | +6.3% | 0.02% | +6.7% |
| Q4 2014 | $1,015,000 | -41.0% | 672,400 | -19.5% | 0.02% | -44.4% |
| Q3 2014 | $1,721,000 | -52.3% | 835,500 | -29.2% | 0.03% | -51.8% |
| Q2 2014 | $3,611,000 | -1.5% | 1,180,000 | -19.5% | 0.06% | -9.7% |
| Q1 2014 | $3,666,000 | -33.5% | 1,466,400 | +32.0% | 0.06% | -25.3% |
| Q4 2013 | $5,509,000 | +434.3% | 1,110,700 | +144.6% | 0.08% | +315.0% |
| Q3 2013 | $1,031,000 | +298.1% | 454,100 | +289.1% | 0.02% | +233.3% |
| Q2 2013 | $259,000 | – | 116,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 1,110,700 | $5,509,000 | 0.08% |
| SABBY MANAGEMENT, LLC | 1,430 | $709,000 | 0.04% |
| Citadel Advisors | 42,500 | $211,000 | 0.00% |